Therapeutic apheresis in pediatrics: technique adjustments, indications and nonindications, a plasma exchange focus

Edward C C Wong1, Rasheed A Balogun

  • 1Division of Laboratory Medicine, Center for Cancer and Blood Disorders, Children's National Medical Center and George Washington School of Medicine and Health Science, Washington, DC, USA. ewong@cnmc.org

Insights

Pediatric therapeutic apheresis presents unique challenges, often relying on adult data. This review focuses on plasma exchange in children, addressing clinical, psychological, and technical adaptations for safe treatment.

Area of Science:

  • Pediatric Nephrology
  • Pediatric Hematology
  • Critical Care Medicine

Background:

  • Therapeutic apheresis in children faces unique challenges, often extrapolated from adult practices.
  • Pediatric-specific clinical, psychological, and technical modifications are crucial for safe and effective treatments.
  • Evidence-based guidelines for pediatric apheresis are often lacking.

Purpose of the Study:

  • To review the unique aspects and challenges of therapeutic apheresis in pediatric patients.
  • To emphasize the performance and considerations for plasma exchange in children.
  • To consolidate knowledge presented at the Therapeutic Apheresis Academy (2011).

Main Methods:

  • Review of literature and clinical practices concerning pediatric therapeutic apheresis.
  • Focus on adaptations required for pediatric plasma exchange.
  • Synthesis of information presented at a specialized academy meeting.

Main Results:

  • Therapeutic apheresis in children requires significant modifications from adult protocols.
  • Plasma exchange is a common apheresis procedure in pediatric care.
  • Addressing psychological and technical aspects is vital for successful pediatric apheresis.

Conclusions:

  • Pediatric therapeutic apheresis necessitates tailored approaches, distinct from adult medicine.
  • Plasma exchange protocols in children require careful consideration of age-specific needs.
  • Further research and evidence-based guidelines are needed for pediatric apheresis.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...